Tapewire

NYSE · USD

LLY

ELI LILLY & Co

Export transactions ↓
Tapewire entity
2794
SEC CIK
0000059478
Parsed reports
2,757

Last 12 months

Inside the activity.

0 purchase rows · 240 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 20250200
Dec 202503
Jan 2026031
Feb 202600
Mar 202600
Apr 202600
May 202602
Jun 202601
Jul 202600
Aug 202603
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 26, 2015 Filed Jan 25, 2016 20:45 UTC
Rice Derica WEVP-Global Services and CFO
GiftCommon Stock 322 $0.00 $0.00
Disclosure

SEC source: 0000059478-16-000243 · wf-form5_145375472634016.xml · nonDerivative · entry 3

Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO

10b5-1 filing: Not disclosed

Ownership: Indirect · by wife

Disclosed balance after: 340,802

F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares.

Read SEC document
October 09, 2015 Filed Oct 13, 2015 18:05 UTC SaleCommon Stock 7,405 $86.44 $640,110.42
Disclosure

SEC source: 0001209191-15-075203 · doc4.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,895,804

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.33 to $86.50, inclusive.

Read SEC document
October 09, 2015 Filed Oct 13, 2015 18:05 UTC SaleCommon Stock 207,595 $85.84 $17,819,332.02
Disclosure

SEC source: 0001209191-15-075203 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,903,209

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.33 to $86.31, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
October 05, 2015 Filed Oct 6, 2015 20:21 UTC SaleCommon Stock 11,300 $87.77 $991,812.30
Disclosure

SEC source: 0001209191-15-074336 · doc4.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,110,804

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.62 to $87.88, inclusive.

Read SEC document
October 05, 2015 Filed Oct 6, 2015 20:21 UTC SaleCommon Stock 53,940 $86.93 $4,689,112.08
Disclosure

SEC source: 0001209191-15-074336 · doc4.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,122,104

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.62 to $87.61, inclusive.

Read SEC document
October 05, 2015 Filed Oct 6, 2015 20:21 UTC SaleCommon Stock 194,760 $86.25 $16,798,634.28
Disclosure

SEC source: 0001209191-15-074336 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,176,044

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.61 to $86.60, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.

Read SEC document
September 30, 2015 Filed Oct 1, 2015 14:21 UTC GrantCommon Stock 113 $87.59 $9,897.67
Disclosure

SEC source: 0000059478-15-000170 · wf-form4_144370928218650.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,241

Read SEC document
September 18, 2015 Filed Sep 21, 2015 18:09 UTC SaleCommon Stock 41,636 $89.66 $3,733,208.67
Disclosure

SEC source: 0001209191-15-071571 · doc4.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,370,804

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.42 to $90.23, inclusive.

Read SEC document
September 18, 2015 Filed Sep 21, 2015 18:09 UTC SaleCommon Stock 208,364 $88.92 $18,527,101.79
Disclosure

SEC source: 0001209191-15-071571 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,412,440

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.42 to $89.41, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
August 31, 2015 Filed Sep 2, 2015 12:25 UTC GrantCommon Stock 119 $83.47 $9,932.93
Disclosure

SEC source: 0000059478-15-000168 · wf-form4_144119673913797.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,969

Read SEC document
July 31, 2015 Filed Aug 4, 2015 15:43 UTC GrantCommon Stock 113 $87.87 $9,929.31
Disclosure

SEC source: 0000059478-15-000166 · wf-form4_143870300729453.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,850

Read SEC document
July 30, 2015 Filed Nov 5, 2015 18:53 UTC
LECHLEITER JOHN CDirector · Chairman, President and CEO
GiftCommon Stock 298 $0.00 $0.00
Disclosure

SEC source: 0000059478-15-000182 · wf-form4_144674957339313.xml · nonDerivative · entry 3

LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 666,014

Read SEC document
July 30, 2015 Filed Jan 25, 2016 20:24 UTC
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
GiftCommon Stock 963 $0.00 $0.00
Disclosure

SEC source: 0000059478-16-000234 · wf-form5_145375346248859.xml · nonDerivative · entry 1

Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,624

Read SEC document
July 28, 2015 Filed Jul 29, 2015 17:30 UTC
Mahony SusanSVP & Pres., Lilly Oncology
SaleCommon Stock 25,000 $84.96 $2,124,000.00
Disclosure

SEC source: 0000059478-15-000161 · wf-form4_143819099484130.xml · nonDerivative · entry 1

Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,728

Read SEC document
July 23, 2015 Filed Jan 25, 2016 20:48 UTC
Ricks David ASVP and Pres, Lilly Bio-Meds
GiftCommon Stock 12 $0.00 $0.00
Disclosure

SEC source: 0000059478-16-000245 · wf-form5_145375492583852.xml · nonDerivative · entry 2

Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,005

Read SEC document
June 30, 2015 Filed Jun 30, 2015 16:41 UTC GrantCommon Stock 120 $82.92 $9,950.40
Disclosure

SEC source: 0000059478-15-000155 · wf-form4_143568249639505.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,737

Read SEC document
June 10, 2015 Filed Jun 11, 2015 19:45 UTC SaleCommon Stock 2,494 $83.43 $208,064.44
Disclosure

SEC source: 0001209191-15-052256 · doc4.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,620,804

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.42 to $83.45, inclusive.

Read SEC document
June 10, 2015 Filed Jun 11, 2015 19:45 UTC SaleCommon Stock 85,926 $82.89 $7,121,976.51
Disclosure

SEC source: 0001209191-15-052256 · doc4.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,623,298

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.42 to $83.405, inclusive.

Read SEC document
June 10, 2015 Filed Jun 11, 2015 19:45 UTC SaleCommon Stock 121,580 $82.02 $9,972,477.92
Disclosure

SEC source: 0001209191-15-052256 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,709,224

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.42 to $82.41, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.

Read SEC document
June 04, 2015 Filed Jun 5, 2015 19:28 UTC SaleCommon Stock 4,700 $78.52 $369,058.10
Disclosure

SEC source: 0001209191-15-050515 · doc4.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,830,804

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.50 to $78.58, inclusive.

Read SEC document
June 04, 2015 Filed Jun 5, 2015 19:28 UTC SaleCommon Stock 195,300 $77.89 $15,210,940.50
Disclosure

SEC source: 0001209191-15-050515 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,835,504

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.49 to $78.495, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
June 04, 2015 Filed Jan 25, 2016 20:54 UTC
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
GiftCommon Stock 4,500 $0.00 $0.00
Disclosure

SEC source: 0000059478-16-000247 · wf-form5_145375523700477.xml · nonDerivative · entry 1

Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,356

Read SEC document
June 01, 2015 Filed Jun 2, 2015 17:56 UTC SaleCommon Stock 220,000 $79.36 $17,460,080.00
Disclosure

SEC source: 0001209191-15-048756 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,030,804

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.87 to $79.84, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
May 29, 2015 Filed Jun 1, 2015 20:28 UTC
Zakrowski Donald AChief Accounting Officer
SaleCommon Stock 200 $78.33 $15,666.00
Disclosure

SEC source: 0000059478-15-000147 · wf-form4_143319046667273.xml · nonDerivative · entry 1

Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,846

Read SEC document
May 29, 2015 Filed Jun 1, 2015 20:31 UTC
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
SaleCommon Stock 20,000 $78.08 $1,561,600.00
Disclosure

SEC source: 0000059478-15-000149 · wf-form4_143319067763029.xml · nonDerivative · entry 1

Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,856

F1 · price: This transaction was executed in multiple trades at prices ranging from $78.01 to $78.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 29, 2015 Filed Jun 1, 2015 20:34 UTC GrantCommon Stock 136 $72.94 $9,919.84
Disclosure

SEC source: 0000059478-15-000151 · wf-form4_143319084598900.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,452

Read SEC document
May 29, 2015 Filed Nov 5, 2015 18:53 UTC
LECHLEITER JOHN CDirector · Chairman, President and CEO
GiftCommon Stock 685 $0.00 $0.00
Disclosure

SEC source: 0000059478-15-000182 · wf-form4_144674957339313.xml · nonDerivative · entry 4

LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 665,329

Read SEC document
May 28, 2015 Filed Nov 5, 2015 18:53 UTC
LECHLEITER JOHN CDirector · Chairman, President and CEO
GiftCommon Stock 11,972 $0.00 $0.00
Disclosure

SEC source: 0000059478-15-000182 · wf-form4_144674957339313.xml · nonDerivative · entry 5

LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 653,357

Read SEC document
May 20, 2015 Filed May 21, 2015 19:57 UTC SaleCommon Stock 190,000 $73.43 $13,951,320.00
Disclosure

SEC source: 0001209191-15-045306 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,250,804

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.19 to $73.69, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
May 15, 2015 Filed May 18, 2015 17:35 UTC SaleCommon Stock 200,000 $72.83 $14,566,400.00
Disclosure

SEC source: 0001209191-15-043646 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,440,804

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.60 to $73.03, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
May 15, 2015 Filed Jan 25, 2016 20:45 UTC
Rice Derica WEVP-Global Services and CFO
GiftCommon Stock 7,800 $0.00 $0.00
Disclosure

SEC source: 0000059478-16-000243 · wf-form5_145375472634016.xml · nonDerivative · entry 2

Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO

10b5-1 filing: Not disclosed

Ownership: Indirect · by wife

Disclosed balance after: 341,124

F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares.

Read SEC document
May 15, 2015 Filed Jan 25, 2016 20:45 UTC
Rice Derica WEVP-Global Services and CFO
GiftCommon Stock 7,800 $0.00 $0.00
Disclosure

SEC source: 0000059478-16-000243 · wf-form5_145375472634016.xml · nonDerivative · entry 1

Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
May 08, 2015 Filed May 11, 2015 17:48 UTC SaleCommon Stock 195,000 $73.28 $14,289,795.00
Disclosure

SEC source: 0001209191-15-040977 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,640,804

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.01 to $73.69, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
May 05, 2015 Filed May 7, 2015 19:07 UTC
Rice Derica WEVP-Global Services and CFO
Exercise / conversionEmployee stock option 5/06 (right to buy) · Derivative 30,000 $0.00 Strike: $52.54 $0.00
Disclosure

SEC source: 0000059478-15-000136 · wf-form4_143102561614503.xml · derivative · entry 10

Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2016-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2015 Filed May 7, 2015 19:07 UTC
Rice Derica WEVP-Global Services and CFO
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative 27,108 $0.00 Strike: $56.18 $0.00
Disclosure

SEC source: 0000059478-15-000136 · wf-form4_143102561614503.xml · derivative · entry 9

Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,108 shares

Expires 2016-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2015 Filed May 7, 2015 19:07 UTC
Rice Derica WEVP-Global Services and CFO
Tax withholdingCommon Stock 25,613 $72.31 $1,852,076.03
Disclosure

SEC source: 0000059478-15-000136 · wf-form4_143102561614503.xml · nonDerivative · entry 4

Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,861

F1 · price: This transaction was executed in multiple trades at prices ranging from $71.98 to $72.93. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 05, 2015 Filed May 7, 2015 19:07 UTC
Rice Derica WEVP-Global Services and CFO
Exercise / conversionCommon Stock 30,000 $52.54 $1,576,200.00
Disclosure

SEC source: 0000059478-15-000136 · wf-form4_143102561614503.xml · nonDerivative · entry 3

Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,474

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2015 Filed May 7, 2015 19:07 UTC
Rice Derica WEVP-Global Services and CFO
Tax withholdingCommon Stock 23,695 $72.31 $1,713,385.45
Disclosure

SEC source: 0000059478-15-000136 · wf-form4_143102561614503.xml · nonDerivative · entry 2

Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,474

F1 · price: This transaction was executed in multiple trades at prices ranging from $71.98 to $72.93. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 05, 2015 Filed May 7, 2015 19:07 UTC
Rice Derica WEVP-Global Services and CFO
Exercise / conversionCommon Stock 27,108 $56.18 $1,522,927.44
Disclosure

SEC source: 0000059478-15-000136 · wf-form4_143102561614503.xml · nonDerivative · entry 1

Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,169

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2015 Filed May 7, 2015 19:08 UTC
Crowe Maria APresident, Mfg. Operations
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative 6,024 $0.00 Strike: $56.18 $0.00
Disclosure

SEC source: 0000059478-15-000138 · wf-form4_143102571161006.xml · derivative · entry 3

Crowe Maria A · CIK 0001538603 · President, Mfg. Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,024 shares

Expires 2016-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2015 Filed May 7, 2015 19:08 UTC
Crowe Maria APresident, Mfg. Operations
Tax withholdingCommon Stock 5,082 $73.05 $371,240.10
Disclosure

SEC source: 0000059478-15-000138 · wf-form4_143102571161006.xml · nonDerivative · entry 2

Crowe Maria A · CIK 0001538603 · President, Mfg. Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,687

Read SEC document
May 05, 2015 Filed May 7, 2015 19:08 UTC
Crowe Maria APresident, Mfg. Operations
Exercise / conversionCommon Stock 6,024 $56.18 $338,428.32
Disclosure

SEC source: 0000059478-15-000138 · wf-form4_143102571161006.xml · nonDerivative · entry 1

Crowe Maria A · CIK 0001538603 · President, Mfg. Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,769

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2015 Filed May 4, 2015 18:58 UTC SaleCommon Stock 200,000 $73.09 $14,617,600.00
Disclosure

SEC source: 0001209191-15-038352 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,835,804

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.87 to $73.305, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
April 30, 2015 Filed Apr 30, 2015 17:33 UTC GrantCommon Stock 137 $72.41 $9,920.17
Disclosure

SEC source: 0000059478-15-000130 · wf-form4_143041522193491.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,316

Read SEC document
April 28, 2015 Filed Apr 30, 2015 17:28 UTC
LECHLEITER JOHN CDirector · Chairman, President and CEO
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative 70,000 $0.00 Strike: $56.18 $0.00
Disclosure

SEC source: 0000059478-15-000126 · wf-form4_143041487471156.xml · derivative · entry 10

LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,964

Underlying: Common Stock · 70,000 shares

Expires 2016-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 28, 2015 Filed Apr 30, 2015 17:28 UTC
LECHLEITER JOHN CDirector · Chairman, President and CEO
Tax withholdingCommon Stock 62,306 $70.89 $4,416,872.34
Disclosure

SEC source: 0000059478-15-000126 · wf-form4_143041487471156.xml · nonDerivative · entry 2

LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 670,110

Read SEC document
April 28, 2015 Filed Apr 30, 2015 17:28 UTC
LECHLEITER JOHN CDirector · Chairman, President and CEO
Exercise / conversionCommon Stock 70,000 $56.18 $3,932,600.00
Disclosure

SEC source: 0000059478-15-000126 · wf-form4_143041487471156.xml · nonDerivative · entry 1

LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 732,416

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 28, 2015 Filed Apr 30, 2015 17:30 UTC
Harrington Michael JSenior VP and General Counsel
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative 6,024 $0.00 Strike: $56.18 $0.00
Disclosure

SEC source: 0000059478-15-000128 · wf-form4_143041504469717.xml · derivative · entry 4

Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,024 shares

Expires 2016-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 28, 2015 Filed Apr 30, 2015 17:30 UTC
Harrington Michael JSenior VP and General Counsel
Tax withholdingCommon Stock 5,184 $70.89 $367,493.76
Disclosure

SEC source: 0000059478-15-000128 · wf-form4_143041504469717.xml · nonDerivative · entry 2

Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,358

Read SEC document
April 28, 2015 Filed Apr 30, 2015 17:30 UTC
Harrington Michael JSenior VP and General Counsel
Exercise / conversionCommon Stock 6,024 $56.18 $338,428.32
Disclosure

SEC source: 0000059478-15-000128 · wf-form4_143041504469717.xml · nonDerivative · entry 1

Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,542

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.